St. Jude Looks To Shoot Down Investors' Stock Fraud Suit

Law360, Los Angeles (October 16, 2013, 7:04 PM EDT) -- St. Jude Medical Inc. sought Tuesday to toss class claims that it illegally inflated its earnings in the third quarter of 2009, saying the investors had failed to prove anything other than the poor economy had hurt its stock price.

The medical device company asked a Minnesota federal judge to toss the suit, saying the class hadn’t presented any evidence of wrongdoing by the company or its executives, and that the earnings miss had simply been a result of some analysts’ predictions that the broader economy...
To view the full article, register now.